Steven A. Julious
Regent Court, 30 Regent Street, S1 4DA
Sheffield, ENG, United Kingdom
Sheffield, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trial.
Journal: The British journal of dermatology
Published: December 18, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trial.
Journal: Orphanet journal of rare diseases
Published: October 23, 2025
Considerations for improving non-inferiority trials.
Journal: Lancet (London, England)
Published: October 10, 2025
A letter intervention to GPs practices to promoting prescription uptake in school-age children with asthma during summer holidays (TRAINS study): a pragmatic cluster randomised controlled trial.
Journal: NPJ primary care respiratory medicine
Published: September 11, 2025
Response adaptive randomisation in clinical trials: Current practice, gaps and future directions.
Journal: Statistical methods in medical research
Published: June 18, 2025
Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension.
Journal: BMJ open
Published: May 21, 2025
Analysis of recurrent events in cluster randomised trials: The PLEASANT trial case study.
Journal: Statistical methods in medical research
Published: May 14, 2025
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phase.
Journal: EClinicalMedicine
Published: March 11, 2025
IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in UK primary care: An internal pilot for a cluster randomised controlled trial.
Journal: PloS one
Published: February 21, 2025
Sample size calculations for pilot cluster-randomised controlled trial: a review 2010-2020.
Journal: Pilot and feasibility studies
Published: November 21, 2024
Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challenges.
Journal: BMC medical research methodology
Published: October 30, 2024
Last Updated: 09/26/2026